Cargando…
ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous Melanoma
Patients with metastatic acral lentiginous melanoma (ALM) suffer worse outcomes relative to patients with other forms of cutaneous melanoma (CM), and do not benefit as well to approved melanoma therapies. Identification of cyclin-dependent kinase 4 and 6 (CDK4/6) pathway gene alterations in > 60%...
Autores principales: | Rebecca, Vito, Jagirdar, Kasturee, Portuallo, Marie, Wei, Meihan, Wilhide, Matthew, Bravo, Jeremy, Robertson, Bailey, Alicea, Gretchen, Aguh, Crsytal, Xiao, Min, Godok, Tetiana, Fingerman, Dylan, Brown, Gregory, Herlyn, Meenhard, Guo, Brian, Toska, Eneda, Zabransky, Daniel, Wubbenhorst, Bradley, Nathanson, Katherine, Kwatra, Shawn, Goyal, Yogesh, Ji, Hongkai, Liu, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153386/ https://www.ncbi.nlm.nih.gov/pubmed/37131684 http://dx.doi.org/10.21203/rs.3.rs-2817876/v1 |
Ejemplares similares
-
Sequential Acral Lentiginous Melanomas of the Foot
por: Uehara, Jiro, et al.
Publicado: (2010) -
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas
por: Rebecca, Vito W., et al.
Publicado: (2023) -
Multiple Primary Acral Lentiginous Melanomas (MPALM)
por: González, Miriam, et al.
Publicado: (2017) -
Dermoscopic features of acral lentiginous melanoma in situ
por: Gao, Fei, et al.
Publicado: (2019) -
A Rare Case of Acral Lentiginous Melanoma
por: Meghe, Soham, et al.
Publicado: (2023)